NCT06703359Recruiting
Predictive Properties of the 6-Minute Stepper Test for Mortality in COPD
Evaluation of the Predictive Properties of the 6-Minute Stepper Test for Long-term Mortality in Patients with COPD
Source: ClinicalTrials.gov · Last updated 2 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Retrospective study aimed to answer the following research questions : * What are the predictive properties of the 6-minute stepper in COPD for 2-year mortality in individuals with COPD ? * What are the predictive properties of the 6-minute stepper in COPD for 5-year mortality in invididuals with COPD ?
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 21 Nov 2024
- Start date
- 1 Jun 2024
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- ADIR Association
- Diseases
- COPD
- NCT number
- NCT06703359
What you commit to
- Study type: Observational
- Planned participants: 250
- From 1 Jun 2024 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not applicable.
Who the study is looking for
- Age \> 18 years;
- Covered by a social security scheme;
- COPD (all stages);
- Referred for pulmonary rehabilitation;
- Completed a 6-Minute Stepper Test at the start of their program.
- Non-inclusion Criteria:
- Patients under guardianship or legal supervision;
- Pregnant or breastfeeding women.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ADIR Association Coordinator of this site? Confirm its status | Rouen | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.